Literature DB >> 11563866

Human papillomavirus and cervical carcinogenesis.

M A Stanley1.   

Abstract

Epidemiological studies show that infection with a subset of genital human papillomavirus (HPV) infections is the major risk factor for the subsequent development of cervical cancer. Experimental studies show that that the E6 and E7 genes of these high risk HPVs are oncogenes that deregulate key cell cycle controls. In the normal infectious cycle high level expression of these genes is confined to non-dividing differentiated cells: HPV oncogenesis requires deregulation of viral and cellular genes permitting inappropriate expression of E6 and E7. These are rare events but viral persistence and chronic exposure to steroid hormones increase the probability of this deregulation. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563866     DOI: 10.1053/beog.2001.0213

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  9 in total

1.  Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.

Authors:  Sojung Lee; Jung-Hee Kim; Heejong Kim; Jeong Woo Kang; Soo-Hyun Kim; Young Yang; Jinman Kim; JongSup Park; SurNie Park; JinTae Hong; Do-Young Yoon
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

2.  Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.

Authors:  K-T Kuo; H-C Chang; C-H Hsiao; M-C Lin
Journal:  Br J Ophthalmol       Date:  2006-03-15       Impact factor: 4.638

Review 3.  Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?

Authors:  Bishr Aldabagh; Jorge Gil C Angeles; Adela R Cardones; Sarah T Arron
Journal:  Dermatol Surg       Date:  2012-08-28       Impact factor: 3.398

4.  Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties.

Authors:  Mahboobeh Safaeian; Koenraad van Doorslaer; Mark Schiffman; Zigui Chen; Ana Cecilia Rodriguez; Rolando Herrero; Allan Hildesheim; Robert D Burk
Journal:  Arch Virol       Date:  2010-01-06       Impact factor: 2.574

5.  Human papillomavirus 16 infection in adenocarcinoma of the cervix.

Authors:  G K Chew; M E Cruickshank; P H Rooney; I D Miller; D E Parkin; G I Murray
Journal:  Br J Cancer       Date:  2005-11-28       Impact factor: 7.640

Review 6.  The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid.

Authors:  Anthonio Adefuye; Arieh Anthony Katz; Kurt Jason Sales
Journal:  Patholog Res Int       Date:  2014-08-11

7.  Depletion of polycistronic transcripts using short interfering RNAs: cDNA synthesis method affects levels of non-targeted genes determined by quantitative PCR.

Authors:  Jennifer E Hanning; Ian J Groves; Mark R Pett; Nicholas Coleman
Journal:  Virol J       Date:  2013-05-21       Impact factor: 4.099

8.  Cancer incidence and mortality in the municipality of Pasto, 1998 - 2007.

Authors:  María Clara Yépez; Luis Eduardo Bravo; Arsenio HidalgoTroya; Daniel Marcelo Jurado; Luisa Mercedes Bravo
Journal:  Colomb Med (Cali)       Date:  2012-12-30

Review 9.  Hygienic hand antiseptics: should they not have activity and label claims against viruses?

Authors:  Syed A Sattar; V Susan Springthorpe; Jason Tetro; Robert Vashon; Bruce Keswick
Journal:  Am J Infect Control       Date:  2002-10       Impact factor: 2.918

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.